Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist
ORIC

Oric Pharmaceuticals (ORIC) stock: insider trades, news & valuation

Heavy selling
Close · Oct 9, 2026 $11.99 -0.3% on the day -14.8% over 12 months 52-week range $7.47 – $14.65

Share price and insider trades

ORIC closeInsider buyInsider sale
58101215NovDecJan 2026FebMarAprMayJunJulAugSepOctSold $3,600 on 2026-07-06 · Richard A. HeymanSold $8,105 on 2026-09-24 · Dominic PiscitelliSold $80,400 on 2026-01-16 · Richard A. HeymanSold $86,524 on 2026-10-01 · Richard A. HeymanSold $157,462 on 2026-07-24 · Richard A. HeymanSold $181,302 on 2026-09-28 · Dominic PiscitelliSold $496,615 on 2025-12-16 · Dominic Piscitelli, Jacob Chacko, Pratik S MultaniSold $702,520 on 2026-02-24 · Dominic PiscitelliSold $1,054,130 on 2026-08-26 · Dominic Piscitelli
Bought, 12 months$0
Sold, 12 months$2.8M
Insiders buying0
Insiders selling4

Oric Pharmaceuticals insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $2.8M of ORIC stock on the open market.

ORIC insider buying and selling by quarter

Open-market purchases (green, above the line) and sales (red, below), by trade date.

Q3 2025: $415K sold (1 trades)Q3 2025Q4 2025: $1.8M sold (6 trades)Q4 2025Q1 2026: $783K sold (3 trades)Q1 2026Q2 2026Q3 2026: $1.4M sold (7 trades)Q3 2026Q4 2026: $87K sold (2 trades)Q4 2026
QuarterBoughtPurchasesSoldSales
Q4 2026—0$87K2
Q3 2026—0$1.4M7
Q2 2026—0—0
Q1 2026—0$783K3
Q4 2025—0$1.8M6
Q3 2025—0$415K1

Valuation, profit and volume

P/E (trailing)n/aSector median —
Market value— 
Profit margin—Revenue growth —
Volume vs. 50-day1.1×Last 5 sessions
Insiders' paper profit—On all tracked purchases —

Summary

Over the past 12 months, 0 Oric Pharmaceuticals, Inc. insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $2.8M. 16 of 19 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.

Insider transactions

Open-market purchases and sales.

Filed Insider Type Shares Price Value Since Score
Oct 2SEC Richard A. HeymanDirector Sell Plan 3,50038,300 held (−8%) $12.91 $45K -7.2% —
Oct 2SEC Richard A. HeymanDirector Sell Plan 3,200203,472 held (−2%) $12.91 $41K -7.2% —
Sep 29SEC Dominic PiscitelliCFO Sell Plan 13,40069,828 held (−16%) $13.53 $181K -11.4% —
Sep 25SEC Dominic PiscitelliCFO Sell Plan 50069,828 held (−1%) $13.51 $7K -11.3% —
Sep 25SEC Dominic PiscitelliCFO Sell Plan 10070,328 held (−0%) $13.50 $1K -11.2% —
Aug 28SEC Dominic PiscitelliCFO Sell Plan 77,00069,828 held (−52%) $13.69 $1.1M -12.4% —
Jul 28SEC Richard A. HeymanDirector Sell Plan 7,00038,300 held (−15%) $12.02 $84K -0.2% —
Jul 28SEC Richard A. HeymanDirector Sell Plan 6,100206,672 held (−3%) $12.02 $73K -0.2% —
Jul 8SEC Richard A. HeymanDirector Sell Plan 300212,772 held (−0%) $12.00 $4K -0.1% —
Feb 26SEC Dominic PiscitelliCFO Sell Plan 52,00068,148 held (−43%) $13.51 $703K -11.3% —
Jan 20SEC Richard A. HeymanDirector Sell Plan 3,50041,800 held (−8%) $12.00 $42K -0.1% —
Jan 20SEC Richard A. HeymanDirector Sell Plan 3,200213,072 held (−1%) $12.00 $38K -0.1% —
Dec 17SEC Jacob ChackoCEO, President Sell 33,374581,711 held (−5%) $9.06 $302K +32.3% —
Dec 17SEC Dominic PiscitelliCFO Sell 10,72068,148 held (−14%) $9.06 $97K +32.3% —
Dec 17SEC Pratik S MultaniChief Medical Officer Sell 10,72068,149 held (−14%) $9.06 $97K +32.3% —
Oct 8SEC Jacob ChackoCEO, President Sell Plan 37,461531,419 held (−7%) $12.32 $462K -2.7% —
Oct 8SEC Dominic PiscitelliCFO Sell Plan 11,00048,317 held (−19%) $14.52 $160K -17.4% —
Oct 2SEC Jacob ChackoCEO, President Sell Plan 53,001568,880 held (−9%) $12.05 $639K -0.5% —
Oct 2SEC Jacob ChackoCEO, President Sell Plan 34,538621,881 held (−5%) $12.01 $415K -0.2% —

Insiders at Oric Pharmaceuticals, Inc.

InsiderBoughtSoldLast filingScore
Dominic PiscitelliCFO — $2.2M Sep 29, 2026 —
Jacob ChackoCEO, President — $1.8M Dec 17, 2025 —
Richard A. HeymanDirector — $328K Oct 2, 2026 —
Pratik S MultaniChief Medical Officer — $97K Dec 17, 2025 —

ORIC stock: common questions

Are Oric Pharmaceuticals, Inc. insiders buying ORIC stock?

In the past 12 months, 0 insiders reported open-market purchases of ORIC worth $0.

Are Oric Pharmaceuticals, Inc. insiders selling ORIC stock?

4 insiders reported sales worth $2.8M over the same period.

Where does this data come from?

Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.

What is ORIC's 52-week range?

Over the past year ORIC has traded between $7.47 and $14.65. It last closed at $11.99 on Oct 9, 2026.